Research suggests the Mammostrat test eventually may be widely used to help make treatment decisions based on whether the cancer has a low or high risk of coming back (recurrence).
Knowing whether a woman has a high or low risk of early-stage breast cancer coming back might help women and their doctors decide if chemotherapy or other treatments to reduce risk after surgery are needed.
- Subtype Of
- Genomic tests
- Medical Conditions
- Breast cancer